Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
aberrant, aforementioned, allogeneic, arbitration, Argentina, Asian, azercabtagene, boosted, CAR, Clawback, conclusion, Cooperation, DAP, depository, disaggregated, EP, EPS, ESG, explanation, extraordinary, factor, FDIC, FIFO, formulary, FRB, genome, geography, GvHD, hardware, Iceland, imaging, Iowa, leadership, licensee, Liechtenstein, loading, magnetic, meant, MHRA, Middle, Neuraxpharm, noncurrent, Norway, officialy, overtime, passage, payer, predominant, predominantly, premium, proceed, rationale, reevaluate, reserve, resonance, separatist, Silicon, simultaneously, software, splitting, stewardship, surface, thirdparty, Treaty, UK, unabsorbed, unconditional, unconditionally, unemployment, unilaterally, Valley, voluntarily, VWAP, zapreleucel
Removed:
abundance, activation, acute, altogether, anticancer, antidilutive, assumption, blood, characterize, chlorambucil, chose, CLL, CohnReznick, comparing, contracting, controlled, curtailed, defer, deferral, element, enterprise, escalating, excluded, expression, fallout, follicular, halt, heading, IA, interpretability, interrupted, leukemia, lineage, lymphoblastic, lymphocytic, malignant, marginal, MEN, missed, NHL, notify, obinutuzumab, ontogeny, OS, outbreak, outlined, overallotment, payroll, PK, placement, plasma, predicated, predicted, proliferation, recommended, red, remarkable, shortfall, SLL, spread, step, subset, suggest, terminal, travel, ubiquitously, underwriter, underwriting, underwritten, unit, updated, withdrawing, worsen, zone
Filing tables
Filing exhibits
Related press release
Associated TGTX transcripts
TGTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statement (No. 333-265838) on Form S-8 and registration statement (No. 333-267262) on Form S-3ASR of our reports dated February 29, 2024, with respect to the consolidated financial statements of TG Therapeutics, Inc. and the effectiveness of internal control over financial reporting.
/s/ KPMG LLP
New York, New York
February 29, 2024